ProShare Advisors LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$29,000
-25.6%
10,284
-19.7%
0.00%
Q4 2021$39,000
-56.7%
12,807
-0.3%
0.00%
Q3 2021$90,000
-37.1%
12,844
-17.4%
0.00%
Q2 2021$143,000
+6.7%
15,541
+12.9%
0.00%
Q1 2021$134,000
+0.8%
13,765
+6.2%
0.00%
Q4 2020$133,000
+30.4%
12,966
+27.9%
0.00%
Q3 2020$102,000
-6.4%
10,136
-2.9%
0.00%
-100.0%
Q2 2020$109,000
-0.9%
10,442
-17.1%
0.00%0.0%
Q4 2019$110,000
-27.2%
12,595
-10.3%
0.00%0.0%
Q3 2019$151,000
-17.5%
14,034
-2.3%
0.00%0.0%
Q2 2019$183,000
-70.7%
14,360
-10.9%
0.00%
-75.0%
Q1 2019$625,000
+92.3%
16,120
+0.8%
0.00%
+100.0%
Q4 2018$325,000
-62.8%
15,992
-16.1%
0.00%
-66.7%
Q3 2018$874,000
-25.1%
19,069
-3.3%
0.01%
-25.0%
Q2 2018$1,167,000
-18.6%
19,725
-6.4%
0.01%
-11.1%
Q1 2018$1,434,000
-40.7%
21,079
-13.9%
0.01%
-47.1%
Q4 2017$2,420,000
+921.1%
24,485
+1139.1%
0.02%
+750.0%
Q3 2017$237,000
+6.8%
1,976
-22.1%
0.00%0.0%
Q2 2017$222,000
-83.2%
2,537
-54.7%
0.00%
-87.5%
Q1 2015$1,321,000
+16.0%
5,596
-7.0%
0.02%
+23.1%
Q4 2014$1,139,000
-51.6%
6,019
-39.0%
0.01%
-58.1%
Q3 2014$2,353,000
+215.0%
9,864
-12.8%
0.03%
+210.0%
Q2 2014$747,000
-68.0%
11,314
-49.5%
0.01%
-65.5%
Q1 2014$2,335,000
+210.9%
22,420
+60.2%
0.03%
+61.1%
Q3 2013$751,00013,9920.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders